RxDoctor Payments Data

Andrea Turek

Medical · Chicago, ILNPI 1669754511

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $112,981 of the $145,301 with a category attached, or 77.8%. AbbVie accounts for 75.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $64,250 and has fallen 67.8% since, to $20,676 in 2025. Among medical clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$145,301in general payments, 2019–2025

Across 389 payments — averaging $373.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$109K
  • Galderma Laboratories, L.p.$23K
  • Merz North America, Inc.$13K
  • Revance Therapeutics, Inc.$143

What the payments were for

  • Speaking & faculty fees$112,98178%
  • Travel & lodging$20,72414%
  • Food & beverage$11,5028%
  • Education$940%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)260$109,014
Galderma Laboratories, L.p.58$22,892
Merz North America, Inc.70$13,252
Revance Therapeutics, Inc.1$143

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$145,301 in reported general payments places this provider in the 95th percentile of 449 medical providers in Illinois.

See all medical providers in Illinois

Other medical in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →